HAE — HAEMONETICS CORP

Ownership history in Caption Management, LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in HAEMONETICS CORP (HAE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.36% (2020 Q2)
Avg. % of fund
0.14%
First filed
2020 Q2
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 200,000 +135,000 +207.7% 0.08% $9.7M $48.74
2024 Q4 REDUCED 65,000 -75,000 -53.6% 0.05% $5.1M $78.08
2024 Q4 ADDED 140,000 +5,000 +3.7% 0.10% $10.9M $78.08
2024 Q3 UNCHANGED 135,000 — 0% 0.17% $10.9M $80.38
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HAE price (monthly, adj. close)

Other funds also holding HAE

As of 2025 Q4 — sorted by position size

North Peak Capital Management, LLC 3Y 7Y 7.51% KESTREL INVESTMENT MANAGEMENT CORP 3Y 7Y 4.46% QSV Equity Investors LLC 1.66% Aristotle Capital Boston, LLC 3Y 7Y 1.63% Sio Capital Management, LLC 3Y 7Y 1.17% BEACON INVESTMENT ADVISORS LLC 3Y 1.02% River Road Asset Management, LLC 3Y 7Y 0.97% Riverwater Partners LLC 3Y 0.96% ISTHMUS PARTNERS, LLC 3Y 7Y 0.6% MIZUHO MARKETS AMERICAS LLC 3Y 0.43%
← Back to Caption Management, LLC Holdings